[Transfection and expression of human thrombopoietin cDNA for treatment of thrombocytopenia in mice].
To explore that COS-7 cells efficiently transfected with human thrombopoietin (hTPO) cDNA from fetal liver and hTPO potentially treated carboplatin-induced thrombocytopenia in mice. Using molecular cloning technique, expression vectors PCIneo under the control of SV40 early. Applying liprofectin mediating method, recombinant plasmids PCIneo-hTPO were transfected into COS-7 cells in addition to effect of G418. After hTPO cDNA and mRNA in colony COS-7 cells were respectively identified by PCR-Southern and dot blot, hTPO was analysed with sandwich ELISA and administrated intraperitoneally to mice with thrombocytopenia. COS-7 cells transfected with constructed PCIneo-hTPO expressed and secreted hTPO up to 48.28 ng/ml in the supernatant. We kinetically observed that the number of megakaryocyte-colony-forming unit (CFU-MK) in bone marrow enhanced to threefold (P < 0.01), especially the number of small CFU-MK, accompanied by an increased mean megakaryocyte volume (P < 0.01) and circulating platelets returned to a normal level (80 +/- 26, x 10(9)/L, P < 0.01) in peripheral blood. Recombinant PCIneo-hTPO can efficiently be transfected into COS-7 cells and hTPO is an effective cytokine for treating carboplatin-induced thrombocytopenia in mice.